Human population genetic structure detected by pain-related mu opioid receptor gene polymorphisms

Genetics and Molecular Biology

Volumn 38, Issue 2, 2015, Pages 152-155

  Soto, Eduardo Javier López ^a   Catanesi, Cecilia Inés ^a,b  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

A118G; AMOVA; OPRM1; Population genetics; SNPs

Indexed keywords

MU OPIATE RECEPTOR;

ANALYSIS OF MOLECULAR VARIANCE; ANALYSIS OF VARIANCE; ARGENTINA; ARTICLE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISTANCE; GENETIC VARIABILITY; HUMAN; NOCICEPTION; OPRM1 GENE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84931422290     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-4757382220140299     Document Type: Article

References (21)

1. Avena S, Via M, Ziv E, Perez-Stable EJ, Gignoux CR, Dejean C, Huntsman S, Torres-Mejia G, Dutil J, Matta JL et al. (2012) Heterogeneity in genetic admixture across different regions of Argentina. PLoS One 7:e34695-34704.
2. Bergen AW, Kokoszka J, Peterson R, Long JC, Virkkunen M, LinnoilaMand Goldman D (1997) Mu opioid receptor gene variants: Lack of association with alcohol dependence. Mol Psychiatry 2:490-494.
3. Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM et al. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc Natl Acad Sci USA 95:9608-9613.
4. Campa D, Gioia A, Tomei A, Poli P and Barale R (2008) Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. Clin Pharmacol Ther 83:559-566.
5. Corach D, Lao O, Bobillo C, van Der Gaag K, Zuniga S, Vermeulen M, van Duijn K, Goedbloed M, Vallone PM, Parson W et al. (2010) Inferring continental ancestry of argentineans from Autosomal, Y-chromosomal and mitochondrial DNA. Ann Hum Genet 74:65-76.
6. Diaz-Lacava A, Walier M, Penacino G, Wienker TF and Baur MP (2011) Spatial assessment of Argentinean genetic admixture with geographical information systems. Forensic Sci Int Genet 5:297-302.
7. Ding S, Chen B, Zheng Y, Lu Q, Liu L and Zhuge QC (2013) Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry 13:107.
8. Excoffier L, Laval G and Schneider S (2005) Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1:47-50.
9. Fernandez Robles CR, Degnan M and Candiotti KA (2012) Pain and genetics. Curr Opin Anaesthesiol 25:444-449.
10. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN et al. (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388-393.
11. Garriock HA, Tanowitz M, Kraft JB, Dang VC, Peters EJ, Jenkins GD, Reinalda MS, McGrath PJ, von Zastrow M, Slager SL et al. (2010) Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. Am J Psychiatry 167:565-573.
12. Gelernter J, Kranzler H and Cubells J (1999) Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: Population studies, and allele frequencies in alcohol- and drugdependent subjects. Mol Psychiatry 4:476-483.
13. Levran O, Awolesi O, Linzy S, Adelson M and Kreek MJ (2011) Haplotype block structure of the genomic region of the mu opioid receptor gene. J Hum Genet 56:147-155.
14. Lopez Soto EJ and Raingo J (2012) A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels. Neurosci Lett 523:190-194.
15. Lopez Soto EJ, Agosti F, Catanesi CI and Raingo J (2013) Impact of A118G Polymorphism on the Mu Opioid Receptor Function in Pain. Journal of Pain & Relief 02:2-6.
16. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C et al. (2009) Expansion of the human mu-opioid receptor gene architecture: Novel functional variants. Hum Mol Genet 18:1037-1051.
17. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R, Teo YY and Tan EC (2008) A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 109:520-526.
18. Sillivan SE, Whittard JD, Jacobs MM, Ren Y, Mazloom AR, Caputi FF, Horvath M, Keller E, Ma’ayan A, Pan YX et al. (2013) ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry 74:511-519.
19. Smith RJ, Doyle GA, Han AM, Crowley JJ, Oslin DW, Patkar AA, Mannelli P, Demaria PA, Jr., O’Brien C P and Berrettini WH (2005) Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. Am J Med Genet B Neuropsychiatr Genet 133B:105-109.
20. Tan EC, Lim EC, Teo YY, Lim Y, Law HY and Sia AT (2009) Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 5:32-40.
21. Ziv E and Burchard EG (2003) Human population structure and genetic association studies. Pharmacogenomics 4:431-441.